Evidence map›Paper›PMID 35458697›Full record

ArticleMolecules (Basel, Switzerland)2022

Panagiotis Kallimanis, Ioanna Chinou, Angeliki Panagiotopoulou, Anatoly A Soshilov, Guochun He, Michael S Denison, Prokopios Magiatis

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Anti-Microorganisms · 2023
    Review
  8. Review
  9. Antioxidants (Basel, Switzerland) · 2023
    Review
  10. Nutrients · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Panagiotis KallimanisLaboratory of Pharmacognosy and Chemistry of Natural Products, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.
Ioanna ChinouLaboratory of Pharmacognosy and Chemistry of Natural Products, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.
Angeliki PanagiotopoulouInstitute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Patr. Gregoriou E & 27 Neapoleos Str., Agia Paraskevi, 15310 Athens, Greece.
Anatoly A SoshilovDepartment of Environmental Toxicology, University of California, Davis, CA 95616, USA.
Guochun HeDepartment of Environmental Toxicology, University of California, Davis, CA 95616, USA.
Michael S DenisonDepartment of Environmental Toxicology, University of California, Davis, CA 95616, USA.
Prokopios MagiatisLaboratory of Pharmacognosy and Chemistry of Natural Products, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.ORCID 0000-0002-0399-5344
National and Kapodistrian University of Athens · GRUniversity of California, Davis · USNational Centre of Scientific Research "Demokritos" · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aryl hydrocarbon receptor (AhR) activation by environmental agents and microbial metabolites is potentially implicated in a series of skin diseases. Hence, it would be very important to identify natural compounds that could inhibit the AhR activation by ligands of microbial origin as 6-formylindolo[3,2-b]carbazole (FICZ), indirubin (IND) and pityriazepin (PZ) or the prototype ligand 2,3,7,8-tetrachlorodibenzo-

Indexed as

Polychlorinated DibenzodioxinsRosmarinusSkin NeoplasmsAnimalsCytochrome P-450 CYP1A1Guinea PigsHumansKeratinocytesLigandsPlant ExtractsReceptors, Aryl HydrocarbonCytochrome P-450 CYP1A1LigandsPlant ExtractsPolychlorinated DibenzodioxinsReceptors, Aryl HydrocarbonAhRFICZhuman keratinocytesindirubinpityriazepinRosmarinus officinalis L.seborrheic dermatitisskin cancerTCDD

Identifiers

PMID35458697
PMCPMC9029298
OpenAlexW4223992591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.